Introduction

LSZ Blotters – 150mcg are an LSZ (lysergic acid 2,4‑dimethylazetidide) research chemical delivered in standardized blotter‑paper format, with each small square labeled at 150mcg to support consistent, low‑mass dosing in analytical and research‑oriented experiments. Blotter‑based carriers are widely used in laboratory settings for studying lysergamide distribution, uniformity, and extraction behavior, and this 150mcg format is particularly suited to laboratories that require clearly defined, easily handled units for tightly controlled, non‑clinical work. This product is supplied exclusively for research‑grade lysergamide applications and is not intended for any use involving human or animal ingestion, treatment, or diagnostic procedures.

Scientific Overview

LSZ (lysergic acid 2,4‑dimethylazetidide, CAS 470666‑31‑0 or closely related variants) is a semisynthetic lysergamide analog of LSD, structurally distinguished by the incorporation of a 2,4‑dimethylazetidide amide group on the lysergic‑acid core, which yields a rigid, conformation‑locked lysergamide structure of interest to pharmacological research. Within the scientific literature, lysergamides of this class are typically characterized for their physicochemical properties, chromatographic profile, and receptor‑binding behavior under strictly controlled, non‑clinical conditions, with no reference to subjective human‑experience data. LSZ Blotters – 150mcg are supplied strictly as a laboratory‑grade lysergamide reference substance and must not be used for diagnostic, therapeutic, or consumer‑oriented purposes.

Product Specifications

• Product Name: LSZ Blotters – 150mcg.

• Chemical Name: Lysergic acid 2,4‑dimethylazetidide (often referred to as LSZ, Diazedine, or Lambda).

• CAS Number: 470666‑31‑0 (or closely related LSZ‑series CAS identifiers depending on supplier).

• Compound Class: Lysergamide research chemical.

• Form: Blotter‑paper squares (laboratory‑grade blotter substrate).

• Dosage per Unit: 150mcg per blotter.

• Purity: Typically ≥ 97–99% research‑grade, where verified by analytical methods such as HPLC, GC‑MS, NMR, or LC‑MS, with trace impurities kept below established laboratory thresholds.

• Molecular Formula: C₂₁H₂₅N₃O.

• Molecular Weight: Approximately 335–336 g/mol.

• Appearance: Uniform small blotter‑paper squares with clearly defined grid‑style markings.

• Quantity: Available in labeled packs (e.g., 5, 10, 25, 50, 100 blotters), enabling repeated use across multiple assay runs and experimental conditions.

• Solubility: Generally soluble in common polar organic solvents such as methanol, ethanol, acetonitrile, and DMSO, supporting controlled extraction into solution for chromatographic or receptor‑binding studies.

• Storage Conditions: Store in a cool, dry, light‑resistant, low‑humidity environment inside sealed, moisture‑resistant, and light‑blocking packaging; refrigeration at 2–8°C is recommended to help preserve the lysergamide on blotter paper and minimize degradation over time.

Laboratory Use Context

LSZ Blotters – 150mcg are intended exclusively for in‑vitro, analytical, and non‑clinical research, including lysergamide stability and decomposition testing on cellulose‑based blotter carriers, controlled extraction experiments, chromatographic method development, and forensic or reference‑material work involving rigid, conformation‑locked lysergamides. The blotter format supports reproducible mass loading, uniform compound distribution, and straightforward documentation of sample preparation steps, making it especially useful for laboratories focused on quantitative profiling, receptor‑binding studies, or method‑validation projects under strict research‑oriented frameworks. This product must not be used in any human or animal‑focused therapeutic, preventive, or diagnostic context and is reserved solely for lawful, laboratory‑based experimentation conducted by qualified personnel.

Quality & Testing

To support rigorous, reproducible science, each batch of LSZ Blotters – 150mcg is accompanied by COA‑based documentation, including batch number, purity estimates, retention‑time data, and a summary of the analytical methods used for characterization where available. Multi‑method verification such as chromatographic profiling, spectrometric analysis, and additional physicochemical tests helps define the material’s profile and reinforces traceability, supporting E‑E‑A‑T‑aligned sourcing for research institutions and analytical laboratories. Clear labeling and batch‑specific records are designed to give laboratories confidence that each blotter unit is consistent, well‑defined, and suitable for tightly controlled experimental work involving lysergamide reference standards.

Shipping & Handling

Orders are discreetly packaged in neutral, light‑resistant, and moisture‑resistant, often foil‑or pouch‑sealed materials to help maintain the integrity of the lysergamide‑laden blotter paper during transit. Discreet worldwide shipping is offered where permitted by local regulations, with batch‑aware handling and tracking features that support secure delivery and logistical transparency. Packaging is designed to minimize exposure to heat, humidity, and physical shocks, further supporting the stability of the material and ensuring that each blotter square remains intact, uncontaminated, and chemically sound upon arrival at the laboratory.

Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product is not intended to diagnose, treat, cure, or prevent any disease and must not be used in any human or animal therapeutic context. LSZ Blotters – 150mcg are strictly reserved for lawful laboratory or analytical research conducted by qualified personnel in accordance with applicable local, national, and international regulations. The legal status of LSZ and related lysergamides varies significantly by jurisdiction, and it is the responsibility of the purchaser to verify compliance with all relevant laws before ordering, receiving, storing, or handling this material.